Accelerate Diagnostics(us:AXDX)

    1.13

    -2.59%

    Updated on 2024-12-23

    Open:1.16
    Close:1.13
    High:1.17
    Low:1.12
    Pre Close:1.16
    Volume:15726.00
    Amount:17901.64
    Turnover:0.06%
    Shares:25.04M
    MarketCap:28.30M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3048425341417.96%2816
    2024-03-3151460233721.10%121014
    2023-12-3143249580917.13%4913
    2023-09-3059255612917.62%8735
    2023-06-306824109561.68%2929
    2023-03-31832459390124.69%91230
    2022-12-31882551759026.18%81536
    2022-09-30912702923127.80%191524
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Armistice Capital, Llc18460008.46%1846000
    2024-03-31Griffin Asset Management, Inc.13542546.21%13453011.03%
    2024-03-31Birchview Capital, Lp3252391.49%10000044.40%
    2024-03-31Vanguard Group Inc3150341.44%83972.74%
    2024-03-31Geode Capital Management, Llc1305930.60%4359050.10%
    2024-03-31Cannell & Spears Llc1146900.53%114690
    2024-03-31Alyeska Investment Group, L.P.805470.37%80547
    2024-03-31Northern Trust Corp627210.29%1660236.00%
    2024-03-31Tci Wealth Advisors, Inc.586800.27%0
    2024-03-31Blackrock Inc.508420.23%0

    About

    Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
    Address:3950 South Country Club Road,Suite 470,4th floor

    Market Movers